ApoE, lipid and immune mechanisms of human neurons and glia
人类神经元和神经胶质细胞的 ApoE、脂质和免疫机制
基本信息
- 批准号:10590145
- 负责人:
- 金额:$ 228.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-15 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAge of OnsetAgingAgonistAllelesAlzheimer&aposs DiseaseApolipoprotein EApolipoproteinsAstrocytesBiologicalBiological AssayBrainCell CommunicationCell DeathCell physiologyCellsCholesterolClinical DataCoculture TechniquesComplementComplement 1qComplexDataEnvironmental Risk FactorEtiologyEventFunctional disorderGenesGeneticGenotypeGlycolipidsHealthHumanImmuneImmune checkpoint inhibitorIn VitroInduced pluripotent stem cell derived neuronsInflammationInflammatoryInvestigationKnock-outKnowledgeLate Onset Alzheimer DiseaseLewy Body DementiaLinkLipid PeroxidationLipidsMeasuresMediatingMetabolicMetabolic ControlMethodologyMicrogliaNPC1 geneNerve DegenerationNeuritesNeurodegenerative DisordersNeurogliaNeuronal DysfunctionNeuronsParkinson DiseasePathogenicityPathologic ProcessesPathologyPathway interactionsPeptidesPhenotypePhysiological ProcessesPoly I-CProcessProtein IsoformsRecombinantsRegulationResolutionSignal TransductionStimulusStressSynapsesSystemTLR3 geneTestingViralage relatedage related neurodegenerationapolipoprotein E-3apolipoprotein E-4cell injurycell typecomplement pathwayexperimental studygenetic risk factorglucosylceramidasehuman stem cellsinduced pluripotent stem celllipid transportpharmacologicresponse
项目摘要
Abstract
There is a significant knowledge gap for how apolipoprotein E (APOE) function can modulate cellular responses
to lipid perturbations and inflammatory mechanisms in the neuron and glia dependent pathophysiology seen in
Lewy body dementia (LBD), Parkinson’s disease (PD), and Alzheimer’s disease (AD). This project will reveal
how APOE can mediate neuronal-glia interactions in their combined responses to lipid and inflammatory
processes.
Appropriate lipid transfer between neurons and glia via lipid transporters such as apolipoproteins, is essential for
maintaining metabolic and structural integrity of neurons, with dysfunction leading to synaptic and cellular
damage. APOE facilitates lipid transport between cells and is also involved in cellular responses to inflammation.
We hypothesize that APOE is a primary point of convergence for mediating neuronal and glial responses to lipid
accumulation and inflammation in the brain in aging and neurodegenerative diseases, and that alterations in
APOE function will modulate downstream pathophysiological mechanisms leading to degeneration. Using our
advanced and refined in vitro platform of human induced pluripotent stem cell (iPSC) derived neurons, astrocytes
and microglia, this proposal addresses new questions of how APOE modulates neuron-glia mechanisms induced
by elevated glycolipids, cholesterol and inflammatory processes, and how such mechanisms are key
determinants in the pathophysiology that leads to LBD, PD and late-onset AD.
To test this hypothesis, we have 2 Specific Aims:
Specific Aim 1 uses APOE3/3, APOE4/4, APOE2/2 and APOEKO human neurons, astrocytes, microglia and
neuron-glia co-cultures, under conditions of elevated glycolipids and cholesterol, achieved through
pharmacological inhibition of glucocerebrosidase and NPC1 pathways. APOE isoform specific function is also
examined using recombinant APOE isoforms. Experiments will measure adaptive and pathophysiological cellular
responses of lipid regulation and transport, structural damage to synapses and neurons, and readouts of cellular
function.
Specific Aim 2 uses the APOE iPSC neuron-glia platform to determine how APOE modulates neuron-glia
pathophysiological responses to inflammatory stimuli, and interactions of APOE with the classical complement
cascade. Experiments will determine APOE-dependent neuron, microglia and astrocyte responses to viral- and
bacterial-like inflammation induced by Poly(I:C) and LPS, on inflammatory pathway activation, APOE-
complement pathway interactions, lipid transport, pre-degenerative changes, and cellular dysfunction.
Clinical data shows that lipid dyshomeostasis and inflammation can significantly contribute to the etiology and
onset of age-related neurodegenerative disorders. The proposed experiments will provide critical neuronal and
glial mechanistic data on how APOE can regulate such lipid and inflammatory disturbances.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PENELOPE Jane HALLETT其他文献
PENELOPE Jane HALLETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PENELOPE Jane HALLETT', 18)}}的其他基金
Parkinsons disease scalable iPSC autologous cell therapy
帕金森病可扩展 iPSC 自体细胞疗法
- 批准号:
10543901 - 财政年份:2020
- 资助金额:
$ 228.43万 - 项目类别:
Prevention of complement and immune-mediated Lewy body dementia
预防补体和免疫介导的路易体痴呆
- 批准号:
9756293 - 财政年份:2018
- 资助金额:
$ 228.43万 - 项目类别:
Prevention of complement and immune-mediated Lewy body dementia
预防补体和免疫介导的路易体痴呆
- 批准号:
10408001 - 财政年份:2018
- 资助金额:
$ 228.43万 - 项目类别:
Prevention of complement and immune-mediated Lewy body dementia
预防补体和免疫介导的路易体痴呆
- 批准号:
10180835 - 财政年份:2018
- 资助金额:
$ 228.43万 - 项目类别:
Prevention of complement and immune-mediated Lewy body dementia
预防补体和免疫介导的路易体痴呆
- 批准号:
9918237 - 财政年份:2018
- 资助金额:
$ 228.43万 - 项目类别:
Critical analysis of glycosphingolipid pathways in aging and Parkinsons disease
衰老和帕金森病中鞘糖脂通路的批判性分析
- 批准号:
8941007 - 财政年份:2015
- 资助金额:
$ 228.43万 - 项目类别:
Critical analysis of glycosphingolipid pathways in aging and Parkinsons disease
衰老和帕金森病中鞘糖脂通路的批判性分析
- 批准号:
9278296 - 财政年份:2015
- 资助金额:
$ 228.43万 - 项目类别:
相似海外基金
Determining the mechanism of action of cis-acting modifiers on the age of onset of Huntington Disease
确定顺式作用修饰剂对亨廷顿病发病年龄的作用机制
- 批准号:
417256 - 财政年份:2019
- 资助金额:
$ 228.43万 - 项目类别:
Studentship Programs
Effect of age of onset of contraception use on brain functioning.
避孕开始年龄对大脑功能的影响。
- 批准号:
511267-2017 - 财政年份:2017
- 资助金额:
$ 228.43万 - 项目类别:
University Undergraduate Student Research Awards
Non-random occurrence and early age of onset of diverse lymphoid cancers in families supports the existence of genetic risk factors for multiple lymphoid cancers.
家族中多种淋巴癌的非随机发生和发病年龄较早,支持多种淋巴癌存在遗传危险因素。
- 批准号:
347105 - 财政年份:2016
- 资助金额:
$ 228.43万 - 项目类别:
Polish-German Child Bilingualism: The Role of Age of Onset for Long-Term Achievement
波兰-德国儿童双语:发病年龄对长期成就的作用
- 批准号:
277135691 - 财政年份:2015
- 资助金额:
$ 228.43万 - 项目类别:
Research Grants
Bioinformatics strategies to relate age of onset with gene-gene interaction
将发病年龄与基因间相互作用联系起来的生物信息学策略
- 批准号:
9097781 - 财政年份:2015
- 资助金额:
$ 228.43万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
9212684 - 财政年份:2014
- 资助金额:
$ 228.43万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
8696557 - 财政年份:2014
- 资助金额:
$ 228.43万 - 项目类别:
Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.
延迟酗酒的发病年龄对青少年大脑发育的影响:在 CO-Venture 试验中添加神经影像测量的建议。
- 批准号:
267251 - 财政年份:2012
- 资助金额:
$ 228.43万 - 项目类别:
Operating Grants
Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers
压力对饮酒的影响:酗酒者的发病年龄和基因
- 批准号:
8606722 - 财政年份:2012
- 资助金额:
$ 228.43万 - 项目类别:
Marijuana: Neurobiologic Correlates of Age of Onset
大麻:发病年龄的神经生物学相关性
- 批准号:
8644793 - 财政年份:2012
- 资助金额:
$ 228.43万 - 项目类别:














{{item.name}}会员




